News

Recently, a delegation of experts from Eurofins GENTIS, led by Dr. Nguyen Quang Vinh (Director of Eurofins GENTIS Testing Center), held a professional working session with the doctors and nurses of the Hanoi General Hospital Assisted Reproduction Center. This collaboration aims to update the latest advances in genetic testing, thereby contributing to improved treatment outcomes for families facing infertility. The session also opened opportunities for academic exchange and laid the groundwork for deeper cooperation between the two units in the future.

To bring greater convenience and cost savings to customers traveling for medical check-ups and testing, Eurofins Gentis has partnered with the Xanh SM mobility app to launch a special promotion for customers commuting to Eurofins Gentis and its nationwide network of medical partners.

On the occasion of welcoming the Lunar New Year 2026, Eurofins Gentis would like to extend our warmest wishes of health, peace, and a fulfilling pregnancy to all expecting mothers and their families. With the desire to accompany mothers on a healthy pregnancy journey, GenEva is launching a special early-year promotion with total benefits of up to VND 3,000,000 for customers who register for the non-invasive prenatal screening (NIPT) test.

At the beginning of 2026, Eurofins Gentis is launching a special promotion offering 20% off all DNA testing services, providing customers with a cost-saving opportunity to access internationally standardized, accurate, and confidential DNA testing services.

Cancer is one of the leading causes of death worldwide. Numerous studies indicate that 5–10% of cancer cases are associated with hereditary factors, resulting from gene mutations that can be passed down from one generation to the next. Hereditary cancer testing helps identify risks early, enabling the development of appropriate monitoring, prevention, and medical intervention strategies.

Eurofins GENTIS solemnly hosted the Year End Party 2025 with the theme “United as One, Steadfast Forward.” The event was not only an occasion to review and reflect on a year of development, but also a meaningful space for connection, where the entire Eurofins GENTIS family gathered, shared, and spread the spirit of unity and determination toward the future.

In recent years, alongside in vitro fertilization (IVF), preimplantation genetic testing (PGT) solutions have increasingly been recognized as a key factor in improving success rates, minimizing risks, and working toward the goal of delivering healthy babies. Scientifically guided embryo selection plays a crucial role in helping clinicians and patients make safer and more effective decisions in each treatment cycle.

In recent years, artificial intelligence (AI) has emerged as one of the key driving forces behind the technological revolution across many fields, especially healthcare. From medical imaging diagnostics and chronic disease management to drug research and development, AI has demonstrated its pivotal role in improving treatment effectiveness and personalizing healthcare. In the field of genetics and assisted reproduction, the integration of AI, bioinformatics, and Omics data is expected to create major breakthroughs, significantly enhancing the quality of screening, diagnosis, and genetic counseling.